**Question:** The proper treatment for lobular carcinoma in situ (LCIS) includes which of the following components?

A. Surgery
B. Radiation therapy
C. Chemotherapy
D. Targeted therapy

**Core Concept:** Lobular carcinoma in situ (LCIS) is a type of breast cancer that occurs in the milk-producing lobules. It is considered a risk factor for the development of invasive breast cancer and requires proper management.

**Why the Correct Answer is Right:**
The correct answer is a combination of surgery and radiation therapy. LCIS is considered a risk factor for developing invasive breast cancer, which requires early intervention to prevent progression. Surgery involves either wide local excision or mastectomy, depending on the extent of the disease. Radiation therapy helps to reduce the risk of developing invasive breast cancer by damaging DNA in cancerous cells and preventing further cell growth and division.

**Why Each Wrong Option is Incorrect:**
A. Chemotherapy: While chemotherapy is a valid treatment option for invasive breast cancer, it is not the primary component of LCIS treatment. Surgery and radiation therapy are considered the standard management for LCIS.

B. Targeted therapy: LCIS is not a targetable condition, as it is a risk factor for invasive breast cancer. Treatment focuses on preventing progression to invasive cancer, rather than targeting LCIS cells directly.

C. Chemoprevention: Chemoprevention refers to the use of medications to prevent the development of cancer. While tamoxifen is used for reducing the risk of invasive breast cancer in women with a high risk of developing breast cancer, it is not a primary component of LCIS treatment. Surgery and radiation therapy are the mainstay of LCIS management.

**Clinical Pearl:**
LCIS is often associated with other risk factors, such as atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS). Early detection and appropriate management of these risk factors can help prevent the development of invasive breast cancer. It is crucial for healthcare professionals to identify and treat LCIS to reduce the risk of invasive cancer and improve patient outcomes.